APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-Thyroid Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Anti-Thyroid Drugs Market Outlook and Growth Opportunities 2026

2 January 2026191 pages

Choose your research edition.

Industry ResearchAnti-Thyroid Drugs Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-Thyroid Drugs Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Anti-Thyroid Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-Thyroid Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-Thyroid Drugs Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Anti-Thyroid Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Anti-Thyroid Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anti-Thyroid Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-Thyroid Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Anti-Thyroid Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Anti-Thyroid Drugs market include Merck and Co., Mylan N.V., GlaxoSmithKline plc, AbbVie and Abbott Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Anti-Thyroid Drugs market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anti-Thyroid Drugs and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anti-Thyroid Drugs revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Anti-Thyroid Drugs market.

Anti-Thyroid Drugs Segment by Company

Merck and Co.

Mylan N.V.

GlaxoSmithKline plc

AbbVie

Abbott Laboratories

Anti-Thyroid Drugs Segment by Type

Oral

Intravenous

Others

Anti-Thyroid Drugs Segment by Application

Online

Offline

Anti-Thyroid Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Anti-Thyroid Drugs status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Anti-Thyroid Drugs key companies, revenue, market share, and recent developments.

3. To split the Anti-Thyroid Drugs breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Anti-Thyroid Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Anti-Thyroid Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Anti-Thyroid Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Thyroid Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-Thyroid Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Thyroid Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Anti-Thyroid Drugs industry.

Chapter 3: Detailed analysis of Anti-Thyroid Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Anti-Thyroid Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Anti-Thyroid Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Anti-Thyroid Drugs Industry Trends Table 2. Anti-Thyroid Drugs Industry Drivers Table 3. Anti-Thyroid Drugs Industry Opportunities and Challenges Table 4. Anti-Thyroid Drugs Industry Restraints Table 5. Global Anti-Thyroid Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Anti-Thyroid Drugs Revenue Share by Company (2021-2026) Table 7. Global Anti-Thyroid Drugs Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Anti-Thyroid Drugs Key Company Manufacturing Base & Headquarters Table 9. Global Anti-Thyroid Drugs Company, Product Type & Application Table 10. Global Anti-Thyroid Drugs Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Anti-Thyroid Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Oral Table 15. Significant Companies of Intravenous Table 16. Significant Companies of Others Table 17. Global Anti-Thyroid Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Anti-Thyroid Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Anti-Thyroid Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Anti-Thyroid Drugs Sales Value Share by Type (2021-2026) Table 21. Global Anti-Thyroid Drugs Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Online Table 23. Significant Companies of Offline Table 24. Global Anti-Thyroid Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Anti-Thyroid Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Anti-Thyroid Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Anti-Thyroid Drugs Sales Value Share by Application (2021-2026) Table 28. Global Anti-Thyroid Drugs Sales Value Share by Application (2027-2032) Table 29. Global Anti-Thyroid Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Anti-Thyroid Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Anti-Thyroid Drugs Sales Value Share by Region (2021-2026) Table 32. Global Anti-Thyroid Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Anti-Thyroid Drugs Sales Value Share by Region (2027-2032) Table 34. Global Anti-Thyroid Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Anti-Thyroid Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Anti-Thyroid Drugs Sales Value Market Share by Country (2021-2026) Table 37. Global Anti-Thyroid Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Anti-Thyroid Drugs Sales Value Market Share by Country (2027-2032) Table 39. Merck and Co. Company Information Table 40. Merck and Co. Business Overview Table 41. Merck and Co. Anti-Thyroid Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Merck and Co. Anti-Thyroid Drugs Product Portfolio Table 43. Merck and Co. Recent Development Table 44. Mylan N.V. Company Information Table 45. Mylan N.V. Business Overview Table 46. Mylan N.V. Anti-Thyroid Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Mylan N.V. Anti-Thyroid Drugs Product Portfolio Table 48. Mylan N.V. Recent Development Table 49. GlaxoSmithKline plc Company Information Table 50. GlaxoSmithKline plc Business Overview Table 51. GlaxoSmithKline plc Anti-Thyroid Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. GlaxoSmithKline plc Anti-Thyroid Drugs Product Portfolio Table 53. GlaxoSmithKline plc Recent Development Table 54. AbbVie Company Information Table 55. AbbVie Business Overview Table 56. AbbVie Anti-Thyroid Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. AbbVie Anti-Thyroid Drugs Product Portfolio Table 58. AbbVie Recent Development Table 59. Abbott Laboratories Company Information Table 60. Abbott Laboratories Business Overview Table 61. Abbott Laboratories Anti-Thyroid Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Abbott Laboratories Anti-Thyroid Drugs Product Portfolio Table 63. Abbott Laboratories Recent Development Table 64. Research Programs/Design for This Report Table 65. Authors List of This Report Table 66. Secondary Sources Table 67. Primary Sources List of Figures Figure 1. Anti-Thyroid Drugs Product Image Figure 2. Global Anti-Thyroid Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-Thyroid Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-Thyroid Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Oral Image Figure 8. Intravenous Image Figure 9. Others Image Figure 10. Global Anti-Thyroid Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Anti-Thyroid Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Anti-Thyroid Drugs Sales Value Share by Type (2021-2032) Figure 13. Online Image Figure 14. Offline Image Figure 15. Global Anti-Thyroid Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Anti-Thyroid Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Anti-Thyroid Drugs Sales Value Share by Application (2021-2032) Figure 18. Global Anti-Thyroid Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Anti-Thyroid Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Anti-Thyroid Drugs Sales Value (2021-2032) & (US$ Million) Figure 21. North America Anti-Thyroid Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Anti-Thyroid Drugs Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Anti-Thyroid Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Anti-Thyroid Drugs Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Anti-Thyroid Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Anti-Thyroid Drugs Sales Value (2021-2032) & (US$ Million) Figure 27. South America Anti-Thyroid Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Anti-Thyroid Drugs Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Anti-Thyroid Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Intravenous
  • Others
Applications
  • Online
  • Offline
Companies covered
  • Merck and Co.
  • Mylan N.V.
  • GlaxoSmithKline plc
  • AbbVie
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Anti-Thyroid Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Anti-Thyroid Drugs Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Anti-Thyroid Drugs Market Dynamics
  1. 2.1 Anti-Thyroid Drugs Industry Trends
  2. 2.2 Anti-Thyroid Drugs Industry Drivers
  3. 2.3 Anti-Thyroid Drugs Industry Opportunities and Challenges
  4. 2.4 Anti-Thyroid Drugs Industry Restraints
3 Anti-Thyroid Drugs Market by Company
  1. 3.1 Global Anti-Thyroid Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Anti-Thyroid Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Anti-Thyroid Drugs Company Ranking (2024-2026)
  4. 3.4 Global Anti-Thyroid Drugs Company Manufacturing Base and Headquarters
  5. 3.5 Global Anti-Thyroid Drugs Company Product Type and Application
  6. 3.6 Global Anti-Thyroid Drugs Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Anti-Thyroid Drugs Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Anti-Thyroid Drugs Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Anti-Thyroid Drugs Market by Type
  1. 4.1 Anti-Thyroid Drugs Type Introduction
  2. 4.1.1 Oral
  3. 4.1.2 Intravenous
  4. 4.1.3 Others
  5. 4.2 Global Anti-Thyroid Drugs Sales Value by Type
  6. 4.2.1 Global Anti-Thyroid Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Anti-Thyroid Drugs Sales Value by Type (2021-2032)
  8. 4.2.3 Global Anti-Thyroid Drugs Sales Value Share by Type (2021-2032)
5 Anti-Thyroid Drugs Market by Application
  1. 5.1 Anti-Thyroid Drugs Application Introduction
  2. 5.1.1 Online
  3. 5.1.2 Offline
  4. 5.2 Global Anti-Thyroid Drugs Sales Value by Application
  5. 5.2.1 Global Anti-Thyroid Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Anti-Thyroid Drugs Sales Value by Application (2021-2032)
  7. 5.2.3 Global Anti-Thyroid Drugs Sales Value Share by Application (2021-2032)
6 Anti-Thyroid Drugs Regional Value Analysis
  1. 6.1 Global Anti-Thyroid Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anti-Thyroid Drugs Sales Value by Region (2021-2032)
  3. 6.2.1 Global Anti-Thyroid Drugs Sales Value by Region: 2021-2026
  4. 6.2.2 Global Anti-Thyroid Drugs Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Anti-Thyroid Drugs Sales Value (2021-2032)
  7. 6.3.2 North America Anti-Thyroid Drugs Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Anti-Thyroid Drugs Sales Value (2021-2032)
  10. 6.4.2 Europe Anti-Thyroid Drugs Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Anti-Thyroid Drugs Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Anti-Thyroid Drugs Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Anti-Thyroid Drugs Sales Value (2021-2032)
  16. 6.6.2 South America Anti-Thyroid Drugs Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Anti-Thyroid Drugs Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Anti-Thyroid Drugs Sales Value Share by Country, 2025 VS 2032
7 Anti-Thyroid Drugs Country-level Value Analysis
  1. 7.1 Global Anti-Thyroid Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Anti-Thyroid Drugs Sales Value by Country (2021-2032)
  3. 7.2.1 Global Anti-Thyroid Drugs Sales Value by Country (2021-2026)
  4. 7.2.2 Global Anti-Thyroid Drugs Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Anti-Thyroid Drugs Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Anti-Thyroid Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Anti-Thyroid Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck and Co.
  2. 8.1.1 Merck and Co. Company Information
  3. 8.1.2 Merck and Co. Business Overview
  4. 8.1.3 Merck and Co. Anti-Thyroid Drugs Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck and Co. Anti-Thyroid Drugs Product Portfolio
  6. 8.1.5 Merck and Co. Recent Developments
  7. 8.2 Mylan N.V.
  8. 8.2.1 Mylan N.V. Company Information
  9. 8.2.2 Mylan N.V. Business Overview
  10. 8.2.3 Mylan N.V. Anti-Thyroid Drugs Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Mylan N.V. Anti-Thyroid Drugs Product Portfolio
  12. 8.2.5 Mylan N.V. Recent Developments
  13. 8.3 GlaxoSmithKline plc
  14. 8.3.1 GlaxoSmithKline plc Company Information
  15. 8.3.2 GlaxoSmithKline plc Business Overview
  16. 8.3.3 GlaxoSmithKline plc Anti-Thyroid Drugs Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GlaxoSmithKline plc Anti-Thyroid Drugs Product Portfolio
  18. 8.3.5 GlaxoSmithKline plc Recent Developments
  19. 8.4 AbbVie
  20. 8.4.1 AbbVie Company Information
  21. 8.4.2 AbbVie Business Overview
  22. 8.4.3 AbbVie Anti-Thyroid Drugs Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AbbVie Anti-Thyroid Drugs Product Portfolio
  24. 8.4.5 AbbVie Recent Developments
  25. 8.5 Abbott Laboratories
  26. 8.5.1 Abbott Laboratories Company Information
  27. 8.5.2 Abbott Laboratories Business Overview
  28. 8.5.3 Abbott Laboratories Anti-Thyroid Drugs Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Abbott Laboratories Anti-Thyroid Drugs Product Portfolio
  30. 8.5.5 Abbott Laboratories Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst